User profiles for D. van Baarle
Debbie van baarleVerified email at rivm.nl Cited by 10776 |
[HTML][HTML] T cell responses to viral infections–opportunities for peptide vaccination
…, J de Jonge, W Luytjes, D van Baarle - Frontiers in …, 2014 - frontiersin.org
An effective immune response against viral infections depends on the activation of cytotoxic
T cells that can clear infection by killing virus-infected cells. Proper activation of these T cells …
T cells that can clear infection by killing virus-infected cells. Proper activation of these T cells …
Cytomegalovirus persistence and T-cell immunosenescence in people aged fifty and older: a systematic review
…, R Eilers, HE de Melker, D van Baarle - Experimental …, 2016 - Elsevier
… Supplementary file D provides an overview of the outcomes from the quality/risk of bias-…
More detailed features of the studies and their limitations are stated in Supplementary file D. …
More detailed features of the studies and their limitations are stated in Supplementary file D. …
[HTML][HTML] Immune activation and collateral damage in AIDS pathogenesis
…, MD Hazenberg, K Tesselaar, D van Baarle… - Frontiers in …, 2013 - frontiersin.org
In the past decade, evidence has accumulated that human immunodeficiency virus (HIV)-induced
chronic immune activation drives progression to AIDS. Studies among different …
chronic immune activation drives progression to AIDS. Studies among different …
[HTML][HTML] Immunogenicity and reactogenicity of vaccine boosters after Ad26. COV2. S priming
…, M Lafeber, D van Baarle… - … England Journal of …, 2022 - Mass Medical Soc
Background The Ad26.COV2.S vaccine, which was approved as a single-shot immunization
regimen, has been shown to be effective against severe coronavirus disease 2019. …
regimen, has been shown to be effective against severe coronavirus disease 2019. …
VDJdb: a curated database of T-cell receptor sequences with known antigen specificity
…, DC Douek, F Luciani, D Van Baarle… - Nucleic acids …, 2018 - academic.oup.com
The ability to decode antigen specificities encapsulated in the sequences of rearranged T-cell
receptor (TCR) genes is critical for our understanding of the adaptive immune system and …
receptor (TCR) genes is critical for our understanding of the adaptive immune system and …
mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non …
…, CACM van Els, NY Rots, D van Baarle… - The Lancet …, 2021 - thelancet.com
… Therefore, to test for non-inferiority, we decided that the anticipated true response rates in
cohorts B, C, and D all had to be equal to the observed true response rate in cohort A (ie, 100%…
cohorts B, C, and D all had to be equal to the observed true response rate in cohort A (ie, 100%…
[HTML][HTML] Impact of delivery mode-associated gut microbiota dynamics on health in the first year of life
M Reyman, MA van Houten, D van Baarle… - Nature …, 2019 - nature.com
The early-life microbiome appears to be affected by mode of delivery, but this effect may
depend on intrapartum antibiotic exposure. Here, we assess the effect of delivery mode on gut …
depend on intrapartum antibiotic exposure. Here, we assess the effect of delivery mode on gut …
γδT cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemia
…, C Donner, B Plachter, D Vermijlen, D van Baarle… - Leukemia, 2013 - nature.com
… (d) The majority of CD8 on γδT cells of congenitally infected newborns is composed of
the CD8αα homodimer. Percentages of CD8+ γδT cells and CD8+ αβT cells … D van Baarle …
the CD8αα homodimer. Percentages of CD8+ γδT cells and CD8+ αβT cells … D van Baarle …
[HTML][HTML] The RECOVAC immune-response study: the immunogenicity, tolerability, and safety of COVID-19 vaccination in patients with chronic kidney disease, on …
Background. In kidney patients COVID-19 is associated with severely increased morbidity
and mortality. A comprehensive comparison of the immunogenicity, tolerability, and safety of …
and mortality. A comprehensive comparison of the immunogenicity, tolerability, and safety of …
[HTML][HTML] Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA …
…, D van Baarle, R van Binnendijk… - The Lancet Infectious …, 2023 - thelancet.com
Background An urgent need exists to improve the suboptimal COVID-19 vaccine response
in kidney transplant recipients (KTRs). We aimed to compare three alternative strategies with …
in kidney transplant recipients (KTRs). We aimed to compare three alternative strategies with …